Exo Acquires Medo To Add Sweep AI To Its POCUS Tech
Executive Summary
Medo’s artificial intelligence technology can make ultrasound images significantly easier to interpret and thereby improve the quality of care with Exo’s point-of-care ultrasound.
You may also be interested in...
Exo Bridges Gaps In Ultrasound Diagnostics By Designing Around The Physician User
The company’s Exo Works system integrates with almost any point-of-care ultrasound device – not just Exo’s – to link ultrasound imaging to electronic medical records, hospital picture archiving, and communication systems.
TCT 2022: Trial Of Boston Scientific’s TAVR Embolic Protector Misses Endpoint, But May Offer 'Hope'
New trial data shows Boston Scientific’s Sentinel cerebral embolic protection device may reduce the risk of disabling stroke, but it does not appear to reduce the overall risk of stroke.
TCT 2022: Edwards Ready To Take On Abbott In Mitral Repair Market With ‘Premium’ Device
Edwards Lifesciences is ramping up US commercialization of its Pascal Precision mitral valve transcatheter edge-to-edge repair device, the first US competitor for Abbott’s MitraClip. The FDA approved Pascal Precision earlier than the company expected, based on results of the CLASP IID trial.